---
title: Optimizing the anesthetic care of patients with aromatic l-amino acid decarboxylase
  deficiency
date: '2024-10-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39435566/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241022193450&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Aromatic l-amino acid decarboxylase (AADC) deficiency is a rare autosomal
  recessive disorder that results in a lack of the monoamine neurotransmitters dopamine,
  serotonin, norepinephrine, and epinephrine. Patients present with a wide spectrum
  of symptoms, including motor and autonomic dysfunction, hypotonia, and developmental
  delay, often before the age of one. Until recently, treatment options were limited
  to symptom control, but the recent approval of the first gene therapy for AADC ...
disable_comments: true
---
Aromatic l-amino acid decarboxylase (AADC) deficiency is a rare autosomal recessive disorder that results in a lack of the monoamine neurotransmitters dopamine, serotonin, norepinephrine, and epinephrine. Patients present with a wide spectrum of symptoms, including motor and autonomic dysfunction, hypotonia, and developmental delay, often before the age of one. Until recently, treatment options were limited to symptom control, but the recent approval of the first gene therapy for AADC ...